Astellas launches initiative against obstetric fistula in Kenya

Astellas has allied with the Fistula Foundation with the aim of transforming the lives of obstetric fistula patients in Kenya.

Funding of 1.5 million euros (1.22 million pounds) has been allocated to the Action on Fistula programme, which will run for three years between now and 2017 and will aid more than 1,200 women affected by the condition.

The money will be used to increase the number of fistula surgeons trained in utilising the International Federation of Gynaecology and Obstetrics Competency-Based Training Programme in Kenya by 100 percent, while significantly boosting the number of surgeries that take place.

Meanwhile, a fistula treatment network across Kenya will also be created and a major outreach programme funded, with community workers identifying and encouraging patients to access available treatment.

Ken Jones, president and chief executive officer of Astellas Pharma Europe, said: "Through our flagship corporate giving programme with the Fistula Foundation, we want to help treat more women living with this devastating condition."

This comes after the firm allied with ClearPath earlier this year on a strategic partnership to accelerate and facilitate the development of new vaccines.